Research news
We have developed some new webpage to help teams and clinicians better understand how to get involved in research. You can explore them here.
New trial of an anti-inflammatory antibiotic for pneumonia in people with a stroke
Pneumonia (a serious infection of the lungs) occurs frequently after a stroke and leads to worse outcomes for patients. Despite modern stroke unit care and antibiotic treatment, the chances of death are three times higher in stroke patients that develop pneumonia, compared to those that don’t. Pneumonia causes excessive, harmful inflammation in the lungs and bloodstream, which is thought to contribute to worse outcomes.
Clarithromycin is a macrolide antibiotic with anti-inflammatory properties. A team led by Professor Craig Smith, the Stroke Research Theme lead in the Geoffrey Jefferson Brain Research Centre and a consultant in stroke medicine at Salford Royal, have been awarded funding from National Institute for Healthcare Research (NIHR) to undertake a phase 3, multi-centre, randomised trial of clarithromycin treatment for stroke patients developing pneumonia. The CLArithromycin for post-Stroke Pneumonia (CLASP) trial will take part in 45 stroke units across the UK and will enrol 1166 people hospitalised with a stroke complicated by pneumonia, within 14 days of admission. The trial will determine whether addition of clarithromycin for 5 days to usual antibiotic treatment, when macrolides are not being given, will improve clinical and health economic outcomes.
HASU and non-HASU sites can participate and Dr Smith's team are really keen to have as many sites in Greater Manchester taking part as possible. CLASP is currently in the set-up phase and will start to enrol participating patients in early 2025. For more information contact craig.smith-2@manchester.ac.uk
TRICEPS study
The TRICEPS (TRanscutaneous lImb reCovEry Post-Stroke) trial investigates whether arm recovery after a stroke can be improved with a treatment called Transcutaneous Vagus Nerve Stimulation (TVNS).
Criteria to take part include:
- Anterior circulation ischaemic stroke between 6 months and 10 years ago and still have arm weakness (Fugyl Meyer 20-50)
- Aged 18+
- Discharged from therapy
- Willing to take part in a trial
- Do not have a pacemaker, cochlear implant or similar
- Willing to commit to a 12 week rehab programme and to travel to site
The trial is looking for new sites, with South Manchester Community Team already successfully recruiting patients. You can read about one of their participants featured in the Manchester Evening news here. Leanne from the team would be happy to speak to anyone interested about their positive experience, please email leanne.calcutt@mft.nhs.uk.
Carer research
Professor Audrey Bowen has asked us to share a summary report of a study by one of her postdoctural students Bethany Harcourt entitled: "Understanding the experience of caring for a friend or family member after their stroke – a research study". You can download the report here. |